Skip to main content
. 2022 Jul 28;23(6):209. doi: 10.1208/s12249-022-02367-w

Table III.

Composition and Characterization of Prepared Solid Dispersion

Compositions Characterization
Polymer Formulation code Drug carrier ratio % yield % drug content Particle size Solubility mg/ml PDI
BEX - - - - 0.00018 -
BEX-POLO1 1:1 92.5±0.8 96.1±1.3 825.0±7.1 0.00162 0.302±21.3
BEX-POLO2 1:2 85.2±1.2 96.9±1.4 721.8±9.1 0.00206 0.401±18.9
POLO BEX-POLO3 1:3 82.9±1.1 97.5±1.1 694.1±3.5 0.00272 0.376±11.1
BEX-POLO4 1:4 79.5±0.9 98.4±1.0 515.2±4.2 0.00356 0.448±14.1
BEX-POLO5 1:5 73.6±1.0 99.1±1.1 471.5±5.3 0.00361 0.396±10.8
BEX-MLBG1 1:1 94.7±0.8 96.3±1.8 918.3±7.1 0.00153 0.089±8.8
BEX-MLBG2 1:2 95.0±1.1 97.1±1.1 875.9±6.5 0.00211 0.115±11.0
MLBG BEX-MLBG3 1:3 94.1±1.2 96.8±1.4 795.3±7,1 0.00284 0.101±10.9
BEX-MLBG4 1:4 95.1±1.4 99.0±1.2 745.7±4.4 0.00340 0.042±15.9
BEX-MLBG5 1:5 95.4±0.9 97.1±1.7 605.8±5.3 0.00344 0.095±11.8